Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Returning to Work: Forecasting the New Normal in Business

Client Alert

We cannot predict when businesses will reopen across the country. As we publish this Alert, dynamic business leaders are cooperating in comprehensive efforts to create safe work environments so that they can all re-engage the workforce.

However, we can predict the new normal in business. Some important studies were published yesterday, and the new normal in business will be facemasks for all employees, and probably all business visitors.

The scientists at the National Institutes of Health published a study yesterday in the New England Journal of Medicine addressing the question of whether the coronavirus can be “aerosolized” when people are speaking. The study advises that the coronavirus can be aerosolized and transmitted between individuals who speak in-person.

In an accompanying commentary to the study, a Harvard University biologist remarked that those aerosols from infected persons may pose a threat, “even at considerable distances and in enclosed spaces,” and identified the wearing of a masks as a prophylactic measure.

Additionally, Nature Medicine published its study yesterday finding that individuals may be infectious for two to three days before showing symptoms of Covid-19.    

What does this mean for employers?

Start sourcing facemasks now. Whether essential or non-essential, healthcare or non-healthcare, all employers will need to have facemasks for employees, and probably visitors, in order to return to new normal operations.  

When combining the studies and the commentary, it makes the current preventative measures (six-foot rule, temperature at door, sending sick employees home, etc.) look less effective than believed. Speaking can be as dangerous as coughs and sneezes. Either by governmental order, regulatory requirement, or to avoid novel claims by employees, employers will need to provide facemasks. 

We expect that additional requirements will also be issued before businesses will reopen, so it probably makes sense to start sourcing disinfectant products at the same time.

For additional information, please contact Jeffrey C. Miller, jcmiller@bmdllc.com or 216.658.2323, or any member of the L+E Team at BMD


Name, Image, and Likeness Agreements in Healthcare

For example, some healthcare providers have begun to utilize "Name, Image, and Likeness" agreements to promote the brand they have created through their healthcare practice.  We have seen the most healthcare NIL activity with longevity and wellness providers, as well as orthopedics.

Compounding GLP-1 Drugs - Recent Updates

Recent guidance from the Ohio Board of Pharmacy (“BOP”) indicates that providers should generally use the FDA approved GLP-1 drug, rather than a non-FDA approved compounded version of the medication. Importantly, if a GLP-1 drug is commercially available, it cannot be copied through compounding. Currently, compounded copies of Tirzepatide and Semaglutide are not permitted.

Top Compliance Risks for Ohio Med-Spas in 2025

The Ohio Board of Pharmacy has increased inspections of med-spas holding Terminal Distributor of Dangerous Drugs (TDDD) licenses, with many facing enforcement actions in 2025. Common issues include purchasing from unlicensed distributors, improper drug storage, inadequate recordkeeping, and insufficient prescriber oversight. Understanding these risks and maintaining compliance can help protect your practice from penalties and license suspension.

Pre and Postnuptial Agreements | Necessary, Maybe, What Happened to Forever?

Both Florida and Ohio now allow clients to enter into a prenuptial or postnuptial agreement prior to marriage or after marriage (Ohio previously did not allow postnuptial agreements). Both documents have statutory guidelines that must be followed in terms of execution and financial disclosure.

DHS Ends All Employment Authorization Auto-Extensions

Effective October 30, 2025, DHS ends all automatic work authorization renewals. The 540-day extension applies only to renewals filed before this date, and there is no grace period for expired EADs filed on or after October 30. Employers must audit EADs, train staff, ensure I-9 compliance, and plan for work authorization gaps. Penalties for noncompliance can be severe.